HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Usefulness of 68 Ga-Pentixafor PET/CT on Diagnosis and Management of Cushing Syndrome.

AbstractPURPOSE:
This pilot study investigated the performance of C-X-C motif chemokine receptor 4 (CXCR4) molecular imaging ( 68 Ga-pentixafor PET/CT) in Cushing syndrome (CS) and the correlation between CXCR4 signaling interactions and glucose metabolism in adrenocorticotropin-cortisol pathway.
METHODS:
We retrospectively evaluated 31 patients (16 patients with CS and 15 patients with nonfunctioning pituitary or adrenal adenomas). All patients underwent 68 Ga-pentixafor PET/CT, and 11 with pituitary adenoma also underwent 18 F-FDG PET/CT. The diagnosis accuracy of 68 Ga-pentixafor PET/CT was calculated. The correlation between radiouptake along the pituitary-adrenal axis and hormone levels was calculated.
RESULTS:
Patients with Cushing disease characterized a focal uptake in adrenocorticotropic hormone-producing pituitary adenoma (ACTH-PA). In ACTH-independent CS, there was increased uptake of 68 Ga-pentixafor in adrenal lesions but not in the pituitary fossa. The nonfunctioning pituitary or adrenal adenomas showed negative 68 Ga-pentixafor signal. The one patient with metastatic ectopic ACTH syndrome had multiple 68 Ga-pentixafor-avid lesions. Using the threshold of SUV max >8.5 in the adrenal lesions, the sensitivity and specificity of 68 Ga-pentixafor PET/CT to diagnose cortisol-producing adenoma were 100% and 84.9%. A cutoff SUV max value of 3.0 on 68 Ga-pentixafor PET/CT had 100% sensitivity and specificity for differentiating ACTH-PA. The corresponding hormone level was significantly correlated with uptake of 68 Ga-pentixafor in pituitary adenoma and adrenal tissue but not with glucose metabolism.
CONCLUSION:
We have characterized the performance of 68 Ga-pentixafor in different subtypes of CS. 68 Ga-pentixafor PET/CT is promising in the differential diagnosis of both ACTH-independent and ACTH-dependent CS. Activated CXCR4 molecular signaling along the pituitary-adrenal axis was found in patients with Cushing disease.
AuthorsJie Ding, Anli Tong, Marcus Hacker, Ming Feng, Li Huo, Xiang Li
JournalClinical nuclear medicine (Clin Nucl Med) Vol. 47 Issue 8 Pg. 669-676 (Aug 01 2022) ISSN: 1536-0229 [Electronic] United States
PMID35452014 (Publication Type: Journal Article)
CopyrightCopyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Chemical References
  • 68Ga-pentixafor
  • Coordination Complexes
  • Peptides, Cyclic
  • Adrenocorticotropic Hormone
  • Glucose
  • Hydrocortisone
Topics
  • Adenoma
  • Adrenocorticotropic Hormone
  • Coordination Complexes
  • Cushing Syndrome (diagnostic imaging)
  • Glucose
  • Humans
  • Hydrocortisone
  • Peptides, Cyclic
  • Pilot Projects
  • Pituitary ACTH Hypersecretion
  • Pituitary Neoplasms (diagnostic imaging)
  • Positron Emission Tomography Computed Tomography (methods)
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: